Exploring the antimicrobial potential of Rosmarinus officinalis against urinary tract infection isolates in Amman, Jordan

Nedaa  Husein; Nidal Abu  Laban; Dima Tareq  Owais

doi:10.18502/ijm.v17i3.18829

Nedaa Husein Department of Allied Medical Sciences, Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan
Nidal Abu Laban Department of Allied Medical Sciences, Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan
Dima Tareq Owais Department of Genetics, Precision Medical Laboratory Group, Amman, Jordan

DOI: https://doi.org/10.18502/ijm.v17i3.18829

Keywords: Rosmarinus; Urinary tract infections; Anti-bacterial agents; Biofilms; Plant extracts; Phytotherapy; Drug resis- tance

Abstract

Background and Objectives: The public health concern about urinary tract infections (UTIs) exists due to mounting an- tibiotic resistance rates. The antimicrobial properties of Rosmarinus officinalis create strong opportunities as an alternative therapeutic option. This study evaluated the antibacterial properties along with anti-biofilm behavior of rosemary extract against typical uropathogens.

Materials and Methods: This study collected samples from 500 UTI isolates for its cross-sectional research. The antibacte- rial activity of rosemary extract underwent testing for its effects on Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, and Pseudomonas aeruginosa through combination tests with disk diffusion, MIC and MBC assays. Biofilm inhi- bition was assessed using the Tissue Culture Plate method with extract concentrations of 25, 50, and 100 µg/mL. Statistical analysis included one-way ANOVA, Tukey's post-hoc, and regression analysis.

Results: The rosemary extract exhibited varying antibacterial effects, with inhibition zones ranging from 10 mm in E. faeca- lis to 16 mm in E. coli. MIC values were 4 mg/mL for E. coli and 32 mg/mL for E. faecalis, while MBC values ranged from 8 to 64 mg/mL. A 100 µg/mL concentration reduced E. coli biofilm formation by 70%. In checkerboard assays, rosemary extract enhanced antibiotic activity against E. coli and showed additive effects with K. pneumoniae and E. faecalis.

Conclusion: R. officinalis extract demonstrates promising antibacterial and anti-biofilm activities, suggesting potential as an adjunct UTI treatment, comparable to co-trimoxazole. Further research is recommended.